Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

TAP Pharmaceutical Products Inc.

TAP began in 1977 as a joint venture between two global pharmaceutical leaders, Abbott, based in the United States, and Takeda Pharmaceutical Company Limited, based in Japan. TAP was created as a kind of "virtual" pharmaceutical company—designed, for example, without any internal discovery organization or manufacturing facilities. From the beginning, the company's corporate structure and business model were unique. TAP went outside for new compounds, and by doing so developed a flexible and versatile culture. At first, TAP acquired early-stage drug compounds solely from one of its parent companies, Takeda. Today TAP works with both Abbott and Takeda and searches the world for in-licensing opportunities, focusing its efforts on rapid, high-quality drug development, and marketing and sales in North America. TAP has built a culture from the bottom up, on a foundation of shared core values; TAP is a place where communication and collaboration are the keys to achieving goals. The people of TAP have created a spirit that is truly remarkable. In TAP's culture, everyone has a voice, and each voice is heard.
This environment has enabled the people of TAP to express their creativity and has fueled the company's constant commitment to innovation. This commitment is evidenced in TAP's approach to science and quality, in the way the employees work with customers, and in TAP's non-traditional approaches to technology, development, and collaboration.
TAP has a culture that combines an endorsement of genuine empowerment of each person with a true entrepreneurial spirit. But TAP is more than a collection of separate efforts. The people of TAP are united by their collective desire to improve the lives of patients, and they find there is a great synergy in working together toward this common goal.


Contact Details:
675 North Field Drive
Lake Forest
Illinois
60045
United States of America
Tel:(847) 582-2000
Fax:
Email:info@tap.com
WWW:

www.tap.com/




Loading...

Recent Publications by TAP Pharmaceutical Products Inc.:

The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
Febuxostat is a novel nonpurine selective inhibitor of xanthine oxidase,...
1st January, 2009
TAP Pharmaceutical Products Inc, Lake Forest, Illinois, USA. J Clin Pharmacol. 2008 Sep;48(9):1014-24. Epub 2008 Jul 17.
DOI Direct Link
Age-dependent pharmacokinetics of lansoprazole in neonates and infants.
BACKGROUND: Evidence suggests that age may affect the pharmacokinetics of...
19th November, 2008
TAP Pharmaceutical Products Inc, Lake Forest, Illinois, USA. Paediatr Drugs. 2008;10(4):265-74.
Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs).
Selective progesterone receptor modulators (SPRMs) represent a new class...
2nd May, 2008
TAP Pharmaceutical Products Inc, Lake Forest, Illinois, USA. Reprod Biol Endocrinol. 2006;4 Suppl 1:S8.
DOI Direct Link
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Xanthine oxidase (XO) expression is increased in the failing heart, and...
15th April, 2008
TAP Pharmaceutical Products Inc., Lake Forest, IL 60045, USA. Life Sci. 2008 Feb 27;82(9-10):495-502. Epub 2008 Jan 24.
DOI Direct Link
Experimental design for regression analysis when the responses are subject to censoring.
Experimental design issues are investigated for regression models with...
20th October, 2007
TAP Pharmaceutical Products Inc., 675 North Field Drive, Lake Forest, IL Comput Methods Programs Biomed. 2007 Aug;87(2):104-11. Epub 2007 Jun 12.
DOI Direct Link

View more TAP Pharmaceutical Products Inc. research publications.

Press Releases on TAP Pharmaceutical Products Inc.:

BioPortfolio Logo
Shire begins the year with a strong performance 30th April, 2009
PHILADELPHIA and DUBLIN, April 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009.
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009 15th April, 2009 Abbott
Quarter Ended 3/31/09 (dollars in millions) % Change vs. 1Q08 Sales Operational Foreign Exchange Reported Total Sales*
Publication of Shire plc's Annual Report 2008 25th March, 2009 Shire Plc
DUBLIN, March 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its Annual Report and Accounts in respect of the year
Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 19th February, 2009
PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 19 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the year to
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings 21st January, 2009 Abbott
ABBOTT PARK, Ill., Jan. 21 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2008. -- Diluted earnings per share,

BioNews Results for TAP Pharmaceutical Products Inc.:

Pediatric Exclusivity Granted
FDA:  Oct 30 2009 6:38PM Matching: tap pharmaceutical products inc
Takeda Pharmaceutical 1st Half Group Net Profit Y189.63 Billion Vs Y71.79 Billion Profit Year Earlier
Morningstar.com:  Oct 30 2009 6:50AM Matching: tap pharmaceutical products inc

TAP Pharmaceutical Products Inc. Patents:

US Patent No.Title
6827208 Packaging system for separately storing and dispensing together separate medication components
6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
6506765 Apomorphine derivatives and methods for their use

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 689 times since April 2007, the link to the organisation's website has been followed 146 times

Recent Search Terms used to find this page: tap science company | tap pharmaceuticals culture change | tap pharmaceuticals Abbott | creativity and innovation in prouducts | tap pharmaceuticals contact number | when did takeda acquire tap | World Biopharmaceutical Product Sales 2009 | takeda acquires TAP Pharmaceutical | 2008 TAP Pharmaceutical annual report | tap pharmaceuticals culture | .

Search for more companies in Lake Forest

Search for more companies in Illinois



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TAP Pharmaceutical Products Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.